Nuvo Pharmaceuticals Inc (MRV.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2021 | 12-2020 | 12-2019 | 12-2018 | 12-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 30,874 | 23,807 | 23,019 | 28,074 | 8,398 |
| Marketable Securities | N/A | N/A | N/A | 0 | 2,000 |
| Receivables | 9,235 | 8,112 | 15,067 | 14,588 | 1,961 |
| Inventories | 8,534 | 9,490 | 7,927 | 13,747 | 2,502 |
| Other current assets | 0 | 0 | 0 | 0 | 117 |
| TOTAL | $50,698 | $43,735 | $47,218 | $58,687 | $15,212 |
| Non-Current Assets | |||||
| PPE Net | 4,103 | 4,505 | 4,423 | 4,659 | 4,283 |
| Intangibles | 75,528 | 100,931 | 111,138 | 120,132 | 10,423 |
| Other Non-Current Assets | 0 | 2,594 | 312 | 18,110 | 0 |
| TOTAL | $79,631 | $108,030 | $115,873 | $142,901 | $14,706 |
| Total Assets | $130,329 | $151,765 | $163,091 | $201,588 | $29,918 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 12,340 | 12,337 | 18,385 | 6,821 | N/A |
| Accounts payable and accrued liabilities | 11,490 | 8,314 | 9,678 | 20,976 | N/A |
| Other current liabilities | 1,360 | 396 | 372 | 408 | 332 |
| TOTAL | $25,190 | $21,756 | $28,443 | $28,287 | $3,466 |
| Non-Current Liabilities | |||||
| Long Term Debt | 83,370 | 91,360 | 104,992 | 117,386 | N/A |
| Other Non-Current Liabilities | 30,461 | 17,988 | 5,265 | 34,910 | 1,301 |
| TOTAL | $116,532 | $109,647 | $110,556 | $152,595 | $1,301 |
| Total Liabilities | $141,722 | $131,403 | $138,999 | $180,882 | $4,767 |
| Shareholders' Equity | |||||
| Common Shares | 184,764 | 184,764 | 184,764 | 184,764 | 0 |
| Retained earnings | -212,797 | -180,592 | -176,501 | -179,862 | -174,877 |
| Other shareholders' equity | 258 | 37 | -63 | 369 | -1 |
| TOTAL | $-11,393 | $20,362 | $24,092 | $20,706 | $25,151 |
| Total Liabilities And Equity | $130,329 | $151,765 | $163,091 | $201,588 | $29,918 |